Evidence map›Paper›PMID 37884489›Full record

ArticleNature communications2023

Small leucine-rich proteoglycans inhibit CNS regeneration by modifying the structural and mechanical properties of the lesion environment.

Julia Kolb, Vasiliki Tsata, Nora John, Kyoohyun Kim, Conrad Möckel, Gonzalo Rosso, Veronika Kurbel, Asha Parmar, Gargi Sharma, Kristina Karandasheva and 17 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Purinergic Receptor P2Y2 Regulates Neurogenesis and Functional Recovery Following Spinal Cord Injury in Zebrafish.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Signal control during tissue regeneration in adult animals.Nature reviews. Molecular cell biology · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. From Biophysics to Biomedical Physics.ACS bio & med chem Au · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Dual role of complement in neuronal repair.Frontiers in immunology · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 7 institutions in 4 countries.

Julia KolbMax Planck Institute for the Science of Light, 91058, Erlangen, Germany.ORCID 0000-0003-2767-4905
Vasiliki Tsata *Experimental Surgery, Clinical and Translational Research Center, Biomedical Research Foundation Academy of Athens, 11527, Athens, Greece.ORCID 0000-0002-7741-9702
Nora John *Max Planck Institute for the Science of Light, 91058, Erlangen, Germany.ORCID 0000-0002-4428-9083
Kyoohyun KimMax Planck Institute for the Science of Light, 91058, Erlangen, Germany.ORCID 0000-0003-1808-775X
Conrad MöckelMax Planck Institute for the Science of Light, 91058, Erlangen, Germany.
Gonzalo RossoMax Planck Institute for the Science of Light, 91058, Erlangen, Germany.
Veronika KurbelDepartment of Neuropathology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054, Erlangen, Germany.ORCID 0000-0003-2586-5409
Asha ParmarMax Planck Institute for the Science of Light, 91058, Erlangen, Germany.ORCID 0000-0002-5630-9483
Gargi SharmaMax Planck Institute for the Science of Light, 91058, Erlangen, Germany.
Kristina KarandashevaDepartment of Neuropathology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054, Erlangen, Germany.ORCID 0000-0003-2919-9458
Shada AbuhattumMax Planck Institute for the Science of Light, 91058, Erlangen, Germany.ORCID 0000-0002-1672-2767
Olga LyrakiMax Planck Institute for the Science of Light, 91058, Erlangen, Germany.
Timon BeckMax Planck Institute for the Science of Light, 91058, Erlangen, Germany.ORCID 0000-0001-8529-5079
Paul MüllerMax Planck Institute for the Science of Light, 91058, Erlangen, Germany.ORCID 0000-0002-5734-3130
Raimund SchlüßlerBiotechnology Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Dresden, Germany.ORCID 0000-0003-3752-2382
Renato FrischknechtDepartment of Biology, Animal Physiology, Friedrich-Alexander-University Erlangen-Nürnberg, 91058, Erlangen, Germany.ORCID 0000-0002-1268-7511
Anja WehnerMass Spectrometry Core Facility, Max Planck Institute of Biochemistry, 82152, Martinsried, Germany.
Nicole KrombholzMass Spectrometry Core Facility, Max Planck Institute of Biochemistry, 82152, Martinsried, Germany.
Barbara SteigenbergerMass Spectrometry Core Facility, Max Planck Institute of Biochemistry, 82152, Martinsried, Germany.
Dimitris BeisExperimental Surgery, Clinical and Translational Research Center, Biomedical Research Foundation Academy of Athens, 11527, Athens, Greece.ORCID 0000-0003-2579-7848
Aya TakeokaVIB-Neuroelectronics Research Flanders, 3001, Leuven, Belgium.
Ingmar BlümckeDepartment of Neuropathology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054, Erlangen, Germany.ORCID 0000-0001-8676-0788
Stephanie MöllmertMax Planck Institute for the Science of Light, 91058, Erlangen, Germany.
Kanwarpal SinghMax Planck Institute for the Science of Light, 91058, Erlangen, Germany.
Jochen GuckMax Planck Institute for the Science of Light, 91058, Erlangen, Germany.ORCID 0000-0002-1453-6119
Katja KobowDepartment of Neuropathology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054, Erlangen, Germany.ORCID 0000-0002-0074-2480
Daniel WehnerMax Planck Institute for the Science of Light, 91058, Erlangen, Germany. daniel.wehner@mpl.mpg.de.ORCID 0000-0003-2880-4759
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEMax Planck Institute for the Science of Light · DEMax Planck Institute of Biochemistry · DEAcademy of Athens · GRAllen Institute for Brain Science · USTechnische Universität Dresden · DEUniversity of Ioannina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular matrix (ECM) deposition after central nervous system (CNS) injury leads to inhibitory scarring in humans and other mammals, whereas it facilitates axon regeneration in the zebrafish. However, the molecular basis of these different fates is not understood. Here, we identify small leucine-rich proteoglycans (SLRPs) as a contributing factor to regeneration failure in mammals. We demonstrate that the SLRPs chondroadherin, fibromodulin, lumican, and prolargin are enriched in rodent and human but not zebrafish CNS lesions. Targeting SLRPs to the zebrafish injury ECM inhibits axon regeneration and functional recovery. Mechanistically, we find that SLRPs confer mechano-structural properties to the lesion environment that are adverse to axon growth. Our study reveals SLRPs as inhibitory ECM factors that impair axon regeneration by modifying tissue mechanics and structure, and identifies their enrichment as a feature of human brain and spinal cord lesions. These findings imply that SLRPs may be targets for therapeutic strategies to promote CNS regeneration.

Indexed as

ProteoglycansSmall Leucine-Rich ProteoglycansAnimalsAxonsCentral Nervous SystemChondroitin Sulfate ProteoglycansDecorinExtracellular Matrix ProteinsHumansMammalsNerve RegenerationZebrafishChondroitin Sulfate ProteoglycansDecorinExtracellular Matrix ProteinsProteoglycansSmall Leucine-Rich Proteoglycans

Identifiers

PMID37884489
PMCPMC10603094
OpenAlexW4387966909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.